Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)

Xiamen Amoytop Biotech Revenue

Xiamen Amoytop Biotech had revenue of 895.81M CNY in the quarter ending September 30, 2026, a decrease of -7.55%. This brings the company's total for the last twelve months to 3.95B, up 18.14% year-over-year. In the year 2025, Xiamen Amoytop Biotech had annual revenue of 3.70B with 31.18% growth. That makes Xiamen Amoytop Biotech the 10,173rd largest company in the world by revenue and 1,649th in China.

• Revenue (ttm): 3.95B
• Revenue Growth: +18.14%
• P/S Ratio: 4.46
• Revenue / Employee: 1.10M
• Employees: 3,640
• Market Cap: 16.76B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• East China 1.34B 36.5%
• Southwest China 678.10M 18.4%
• Central China 500.97M 13.6%
• North China 440.34M 12.0%
• South China 331.89M 9.0%
• Northwest China 254.17M 6.9%
• Northeast China 124.23M 3.4%
• Overseas 8.09M 0.2%

Fiscal year ended Dec 31, 2025 See the full Xiamen Amoytop Biotech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.70B	878.41M	31.18%
Dec 31, 2024	2.82B	716.84M	34.13%
Dec 31, 2023	2.10B	573.42M	37.55%
Dec 31, 2022	1.53B	394.68M	34.86%
Dec 31, 2021	1.13B	338.29M	42.61%

Data Source: S&P Global Market Intelligence Last updated: Oct 22, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error